(Q47637552)

English

Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study

scientific article published on 19 October 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/26478208

Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/26478208

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Y-D Hu

1

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/26478208

Y-T Xiang

2

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/26478208

J-X Fang

3

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/26478208

S Zu

4

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/26478208

S Sha

5

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/26478208

H Shi

6

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/26478208

G S Ungvari

7

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/26478208

C U Correll

8

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/26478208

H F K Chiu

9

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/26478208

Y Xue

10

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/26478208

T-F Tian

11

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/26478208

A-S Wu

12

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/26478208

X Ma

13

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/26478208

G Wang

14

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/26478208

language of work or name

0 references

publication date

19 October 2015

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/26478208

Psychological Medicine

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/26478208

46

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/26478208

3

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/26478208

623-635

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/26478208

Increased anterior cingulate cortical activity in response to fearful faces: a neurophysiological biomarker that predicts rapid antidepressant response to ketamine.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

21 January 2018

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

21 January 2018

Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

21 January 2018

Antidepressant effects of ketamine in depressed patients

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

21 January 2018

Efficacy of ECT in depression: a meta-analytic review

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

21 January 2018

Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

21 January 2018

Ketamine for depression: where do we go from here?

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

21 January 2018

Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

21 January 2018

A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

21 January 2018

Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

21 January 2018

Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

21 January 2018

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

21 January 2018

A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

21 January 2018

Ketamine for treatment-resistant unipolar depression: current evidence

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

21 January 2018

Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

21 January 2018

Psychometric properties of the Chinese versions of the Quick Inventory of Depressive Symptomatology - Clinician Rating (C-QIDS-C) and Self-Report (C-QIDS-SR).

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

21 January 2018

Frontal white matter abnormalities following chronic ketamine use: a diffusion tensor imaging study

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

21 January 2018

Reduced dorsal prefrontal gray matter after chronic ketamine use.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

21 January 2018

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

21 January 2018

A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

21 January 2018

A randomized controlled trial of intranasal ketamine in major depressive disorder

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

21 January 2018

Derivation of a definition of remission on the Montgomery-Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for depression.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

21 January 2018

Ketamine Anesthesia

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

21 January 2018

Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

21 January 2018

Ketamine as a new treatment for depression: a review of its efficacy and adverse effects

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

21 January 2018

Antidepressants and the risk of suicidal behaviors

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

21 January 2018

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

21 January 2018

Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

21 January 2018

Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

21 January 2018

Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

21 January 2018

A rating scale for mania: reliability, validity and sensitivity

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

21 January 2018

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

21 January 2018

Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

21 January 2018

Rapid response with ketamine on suicidal cognition in resistant depression

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

21 January 2018

Metabotropic glutamate receptor 7: at the interface of cognition and emotion

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

21 January 2018

Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

21 January 2018

Glutamate-based antidepressants: 20 years on.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

21 January 2018

Ketamine administration in depressive disorders: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

21 January 2018

A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

21 January 2018

The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

21 January 2018

Speed of Response and Remission in Major Depressive Disorder With Acute Electroconvulsive Therapy (ECT)

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

7 January 2021

based on heuristic

inferred from DOI database lookup

Ketamine decreases resting state functional network connectivity in healthy subjects: implications for antidepressant drug action

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

7 January 2021

based on heuristic

inferred from DOI database lookup

Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS)

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715002159

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1017/S0033291715002159

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/26478208

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/26478208

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47637552&oldid=2163879458"